SOD1 and Parkinsonism: Here we show that treatment of SOCK mice with the blood-brain-barrier-permeable copper delivery drug, diacetyl-bis(4-methylthiosemicarbazonato)copper(II) (CuATSM), mitigates the formation of Parkinson-like wild-type SOD1 pathology, increases SN dopamine neuron survival and improves motor function.